Clinical Trial Update: CKD-828 (80/5mg) Pharmacokinetic Study [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of CKD-828 (80/5 mg) in hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• CKD-828

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Hypertension | Phase 1 | Status: COMPLETED